The long-running krill oil patent dispute between Canada’s Neptune Technologies & Bioressources and Israel-based Enzymotec Ltd. has come to an end, with the firms signing a final and binding patent infringement settlement and license agreement.
In a new phase of a long-standing krill oil patent dispute, Israel-based Enzymotec Ltd. has backed out of a settlement negotiation with Canada’s Neptune Technologies & Bioressources, both companies confirm. Enzymotec said it halted negotiations after...
The lengthy court battles in the krill sector took a new turn when the category’s newest entrant, Rimfrost, settled a patent dispute and entered into a supply agreement with Neptune Technologies and Bioressources, the company that first brought krill...
Neptune Technologies and Bioressources has filed ‘continuation’ applications with the US Patent & Trademark Office (USPTO) it says will allow it to pursue “additional patent claims that should preclude our competitors from selling their krill oil...
Suggestions by Aker Biomarine that Neptune Technologies and Bioressources misrepresented the novelty of the inventions claimed in its newly-granted krill oil patent are “baseless”, Neptune bosses have insisted.
Israeli nutritional lipids giant Enzymotec has weighed into the patent infringement row engulfing the krill oil industry with a statement from its boss declaring rival Neptune’s new US patent for marine phospholipids ‘invalid’ and ‘unenforceable’ and...
Neptune Technologies & Bioressources has reported increased
sales for its second quarter, as the firm continues development
work with Nestle and Yoplait on its flagship krill oil product.
Neptune Technologies & Bioressources's efforts to spread the
word about Neptune Krill Oil and an internal reorganisation are
paying off, as the Canadian manufacturer has reported a significant
increase in sales and a decrease...
Neptune Technologies & Bioressources is currently designing a
large scale cognitive study on its proprietary Neptune Krill Oil,
following positive results in a recent clinical study on the
marine-derived ingredient and adult ADHD.
Neptune Technologies & Bioressources has announced the closing
of a $4.5mn private placement of common shares, which is designed
to help accelerate its business strategy and boost R&D efforts.
Neptune Technologies & Bioressources of Canada has said it will
reach profitability next year thanks to the first order for its
marine oil extracted from krill sold under the brand name NKO.